LENZ Therapeutics (LENZ) Enterprise Value (2020 - 2026)
LENZ Therapeutics (LENZ) reported Enterprise Value of -$258.4 million for Q1 2026, down 1015.84% year-over-year from $28.2 million in Q1 2025, and up 11.62% on a QoQ basis from -$292.3 million in Q4 2025.
LENZ Therapeutics (LENZ) has 7 years of Enterprise Value data on file, last reported at -$258.4 million in Q1 2026.
- Quarterly Enterprise Value fell 1015.84% year-over-year to -$258.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$258.4 million (down 1015.84% YoY) and the FY2025 annual result came in at -$292.3 million, down 1342.12% from the prior year.
- Enterprise Value rose to -$258.4 million in Q1 2026 per LENZ's latest filing, from -$292.3 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$20.3 million in Q4 2024 and bottomed at -$339.2 million in Q1 2022.
- The 5-year median for Enterprise Value is -$217.1 million (2024), against an average of -$194.5 million.
- Peak annual rise in Enterprise Value reached 88.45% in 2025, while the deepest fall reached 1342.12% in 2025.
- Tracing LENZ's Enterprise Value over 5 years: stood at -$268.2 million in 2022, then soared by 75.47% to -$65.8 million in 2023, then surged by 69.19% to -$20.3 million in 2024, then slumped by 1342.12% to -$292.3 million in 2025, then grew by 11.62% to -$258.4 million in 2026.
- Per Business Quant, the three latest LENZ Enterprise Value figures stand at -$258.4 million (Q1 2026), -$292.3 million (Q4 2025), and -$202.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.32 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -32.30 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -286.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -61.46 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.77 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -7.25 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -18.44 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -8.75 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -3.01 Bn |
| 10 | LENZ Therapeutics | 235.77 Mn | 235.77 Mn | 825,000.00 | -258.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -258.39 Mn |
| Dec 31, 2025 | -292.35 Mn |
| Sep 30, 2025 | -202.17 Mn |
| Jun 30, 2025 | -37.71 Mn |
| Mar 31, 2025 | -23.16 Mn |
| Dec 31, 2024 | -20.27 Mn |
| Sep 30, 2024 | -217.11 Mn |
| Jun 30, 2024 | -84.14 Mn |
| Mar 31, 2024 | -200.46 Mn |
| Dec 31, 2023 | -65.79 Mn |
| Sep 30, 2023 | -233.99 Mn |
| Jun 30, 2023 | -246.67 Mn |
| Mar 31, 2023 | -202.25 Mn |
| Dec 31, 2022 | -268.23 Mn |
| Sep 30, 2022 | -291.69 Mn |
| Jun 30, 2022 | -322.29 Mn |
| Mar 31, 2022 | -339.18 Mn |
| Dec 31, 2021 | -376.98 Mn |
| Sep 30, 2021 | -394.95 Mn |
| Jun 30, 2021 | -382.11 Mn |
| Mar 31, 2021 | -177.02 Mn |
| Dec 31, 2020 | -19.82 Mn |
| Sep 30, 2020 | -10.58 Mn |
| Jun 30, 2020 | -13.67 Mn |